|
Alpharma makes medicines for all of the world's creatures. The company operates in two segments, human pharmaceuticals and animal health. Alpharma's human pharmaceuticals business makes branded drugs for chronic pain control, including Kadian, an extended-release morphine in capsule form, and Flector, an anti-inflammatory pain relief patch. The company's animal health segment caters to the rest of the animal kingdom; its animal antibiotics and feed additives are sold to livestock producers and feed makers. Its products are manufactured by a third party. Alpharma has agreed to be acquired by King Pharmaceuticals.
|
| | | Contact Information | |
Address: |
440 Rte., 22 East
Bridgewater, NJ 08807
| | Phone: | 908-566-3800 | | Fax: | 908-566-4137 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2007): | 722.40 M | | Revenue Growth (1 yr): | 10.50% |
|
|
Key People
| | • |
Chairman:
Peter G. Tombros
| | • |
President, CEO, and Director:
Dean J. Mitchell
| | • |
EVP and CFO:
Jeffrey S. Campbell
|
|
|
